Point: Abnormalities of foetal growth-Is it time to move towards a personalised medicine approach to predict adverse neonatal outcomes?

Paediatr Perinat Epidemiol. 2024 Jan;38(1):12-14. doi: 10.1111/ppe.13019. Epub 2023 Dec 11.

Authors

Katherine L Grantz¹, Jun Zhang²

Affiliations

¹ Epidemiology Branch, Division of Population Health Research, Division of Intramural Research Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
² International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

PMID: 38078856
PMCID: PMC10872796 (available on 2025-01-01)
DOI: 10.1111/ppe.13019

No abstract available

MeSH terms

Fetal Development*
Humans
Infant, Newborn
Precision Medicine*

Grants and funding

Z99 HD999999/ImNIH/Intramural NIH HHS/United States